Suzhou Basecare Medical Corporation Limited (HKG:2170)

Market Cap	899.90M
Revenue (ttm)	318.30M
Net Income (ttm)	-252.24M
Shares Out	273.53M
EPS (ttm)	-0.92
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000
Average Volume	76,100
Open	3.200
Previous Close	3.290
Day's Range	3.200 - 3.200
52-Week Range	1.290 - 4.450
Beta	0.20
RSI	49.24
Earnings Date	May 29, 2025

About HKG:2170

Suzhou Basecare Medical Corporation Limited, an investment holding company provides genetic testing solutions for assisted human reproduction in the People’s Republic of China and Australia. The company offers genetic test kit products, which include pre-implantation genetic test kits, such as PGT-A to detect aneuploidy; PGT-M to detect single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kits to detect chromosome structural rearrangements, which are common causes of recurrent miscarriage. It also offers liquid nitrogen stor...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 497
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2170

Financial Performance

In 2024, HKG:2170's revenue was 299.11 million, an increase of 43.82% compared to the previous year's 207.98 million. Losses were -237.03 million, 23.7% more than in 2023.

Financial numbers in CNY